Autoinjectors

Autoinjectors

The global economy is at a critical crossroads with a number of interlocking challenges and crises running in parallel. The uncertainty around how Russia`s war on Ukraine will play out this year and the war`s role in creating global instability means that the trouble on the inflation front is not over yet. Food and fuel inflation will remain a persistent economic problem. Higher retail inflation will impact consumer confidence and spending. As governments combat inflation by raising interest rates, new job creation will slowdown and impact economic activity and growth. Lower capital expenditure is in the offing as companies go slow on investments, held back by inflation worries and weaker demand. With slower growth and high inflation, developed markets seem primed to enter into a recession. Fears of new COVID outbreaks and China’s already uncertain post-pandemic path poses a real risk of the world experiencing more acute supply chain pain and manufacturing disruptions this year. Volatile financial markets, growing trade tensions, stricter regulatory environment and pressure to mainstream climate change into economic decisions will compound the complexity of challenges faced. Year 2023 is expected to be tough year for most markets, investors and consumers. Nevertheless, there is always opportunity for businesses and their leaders who can chart a path forward with resilience and adaptability.

Global Autoinjectors Market to Reach $168.2 Billion by 2030
In the changed post COVID-19 business landscape, the global market for Autoinjectors estimated at US$50.9 Billion in the year 2022, is projected to reach a revised size of US$168.2 Billion by 2030, growing at a CAGR of 16.1% over the analysis period 2022-2030. Rheumatoid Arthritis, one of the segments analyzed in the report, is projected to record a 16% CAGR and reach US$47.6 Billion by the end of the analysis period. Taking into account the ongoing post pandemic recovery, growth in the Anaphylaxis segment is readjusted to a revised 15.9% CAGR for the next 8-year period.

The U.S. Market is Estimated at $13.9 Billion, While China is Forecast to Grow at 21.4% CAGR
The Autoinjectors market in the U.S. is estimated at US$13.9 Billion in the year 2022. China, the world`s second largest economy, is forecast to reach a projected market size of US$40.4 Billion by the year 2030 trailing a CAGR of 21.4% over the analysis period 2022 to 2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at 11.9% and 13.8% respectively over the 2022-2030 period. Within Europe, Germany is forecast to grow at approximately 12.8% CAGR. Led by countries such as Australia, India, and South Korea, the market in Asia-Pacific is forecast to reach US$26.4 Billion by the year 2030.

Select Competitors (Total 42 Featured) -
  • AbbVie, Inc.
  • Amgen, Inc.
  • Antares Pharma, Inc.
  • Becton, Dickinson and Company
  • Consort Medical PLC
  • Eli Lilly and Company
  • Haselmeier GmbH
  • Mylan NV
  • Owen Mumford Ltd.
  • SHL Group
  • Teva Pharmaceutical Industries Ltd.
  • Ypsomed AG
Please note: Reports are sold as single-site single-user licenses. Electronic versions require 24-48 hours as each copy is customized to the client with digital controls and custom watermarks. The Publisher uses digital controls protecting against copying and printing is restricted to one full copy to be used at the same location.

The latest version of Adobe Acrobat Reader is required to view the report. Upon ordering an electronic version, the Publisher will provide a link to download the purchased report.

Prior to fulfillment of an order, the client will be required to sign a document detailing the purchase terms for a publication from this publisher.


I. METHODOLOGY
II. EXECUTIVE SUMMARY
1. MARKET OVERVIEW
Influencer Market Insights
World Market Trajectories
Rapid Shift from Self-Injectors to Autoinjectors for Easy and Safe Administration of Drugs Drives Demand
North America: The Largest Market for Autoinjectors
Autoinjectors – Global Key Competitors Percentage Market Share in 2022 (E)
Global Epinephrine Autoinjector market: Percentage Breakdown of Volume Sales by Leading Players for the Year 2019E
Impact of Covid-19 and a Looming Global Recession
Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2022 (E)
2. FOCUS ON SELECT PLAYERS
3. MARKET TRENDS & DRIVERS
Rising Prevalence of Targeted Therapies such as Cancer, Rheumatoid Arthritis, Multiple Sclerosis and Diabetes: A Strong Growth Driver
Number of New Cases of Cancer Worldwide for the Years 2012, 2015, 2020, 2025 and 2030
Diabetes Prevalence in the Age-Group of 20-79 Years in Millions by Region for the Years 2018, 2021 and 2025
Global Injectable Drug Delivery Market: Revenues in US$ Billion for the Years 2016, 2018, 2020, 2022 and 2024
Rising Incidence of Anaphylaxis and Increased Prescription Rate of Epinephrine Autoinjectors Boosts Market Demand
Increasing Number of Regulatory Approvals for Autoinjectors in Various Diseases
Generic Autoinjectors Take Center Stage
Patent Expiry of Biologics to Drive the Demand for Biosimilars
Strong Government Support and Favorable Reimbursement Policies Propel Market Growth
Challenges
Development of Autoinjectors for Multiple Drug Viscosities: A Major Challenge
Increasing Demand for Alternative Drug Delivery Modes Hampers Market Growth
Emergence of Oral Diabetic Agents, Oral Insulin and Epinephrine Nasal Sprays Poses Huge Challenge for Autoinjectors Market
Product Overview
Autoinjector: Definition
4. GLOBAL MARKET PERSPECTIVE
TABLE 1: World Recent Past, Current & Future Analysis for Autoinjectors by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2022 through 2030 and % CAGR
TABLE 2: World Historic Review for Autoinjectors by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
TABLE 3: World 16-Year Perspective for Autoinjectors by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets for Years 2014, 2023 & 2030
TABLE 4: World Recent Past, Current & Future Analysis for Rheumatoid Arthritis by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2022 through 2030 and % CAGR
TABLE 5: World Historic Review for Rheumatoid Arthritis by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
TABLE 6: World 16-Year Perspective for Rheumatoid Arthritis by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2023 & 2030
TABLE 7: World Recent Past, Current & Future Analysis for Multiple Sclerosis by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2022 through 2030 and % CAGR
TABLE 8: World Historic Review for Multiple Sclerosis by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
TABLE 9: World 16-Year Perspective for Multiple Sclerosis by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2023 & 2030
TABLE 10: World Recent Past, Current & Future Analysis for Anaphylaxis by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2022 through 2030 and % CAGR
TABLE 11: World Historic Review for Anaphylaxis by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
TABLE 12: World 16-Year Perspective for Anaphylaxis by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2023 & 2030
TABLE 13: World Recent Past, Current & Future Analysis for Diabetes by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2022 through 2030 and % CAGR
TABLE 14: World Historic Review for Diabetes by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
TABLE 15: World 16-Year Perspective for Diabetes by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2023 & 2030
TABLE 16: World Recent Past, Current & Future Analysis for Other Therapies by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2022 through 2030 and % CAGR
TABLE 17: World Historic Review for Other Therapies by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
TABLE 18: World 16-Year Perspective for Other Therapies by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2023 & 2030
TABLE 19: World Autoinjectors Market Analysis of Annual Sales in US$ Million for Years 2014 through 2030
TABLE 20: World Recent Past, Current & Future Analysis for Disposable Autoinjectors by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2022 through 2030 and % CAGR
TABLE 21: World Historic Review for Disposable Autoinjectors by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
TABLE 22: World 16-Year Perspective for Disposable Autoinjectors by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2023 & 2030
TABLE 23: World Recent Past, Current & Future Analysis for Reusable Autoinjectors by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2022 through 2030 and % CAGR
TABLE 24: World Historic Review for Reusable Autoinjectors by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
TABLE 25: World 16-Year Perspective for Reusable Autoinjectors by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2023 & 2030
TABLE 26: World Recent Past, Current & Future Analysis for Home Care Settings by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2022 through 2030 and % CAGR
TABLE 27: World Historic Review for Home Care Settings by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
TABLE 28: World 16-Year Perspective for Home Care Settings by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2023 & 2030
TABLE 29: World Recent Past, Current & Future Analysis for Hospitals & Clinics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2022 through 2030 and % CAGR
TABLE 30: World Historic Review for Hospitals & Clinics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
TABLE 31: World 16-Year Perspective for Hospitals & Clinics by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2023 & 2030
TABLE 32: World Recent Past, Current & Future Analysis for Ambulatory Care Settings by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2022 through 2030 and % CAGR
TABLE 33: World Historic Review for Ambulatory Care Settings by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
TABLE 34: World 16-Year Perspective for Ambulatory Care Settings by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2023 & 2030
III. MARKET ANALYSIS
UNITED STATES
Autoinjectors Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2023 (E)
TABLE 35: USA Recent Past, Current & Future Analysis for Autoinjectors by Therapy - Rheumatoid Arthritis, Anaphylaxis, Multiple Sclerosis, Diabetes and Other Therapies - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
TABLE 36: USA Historic Review for Autoinjectors by Therapy - Rheumatoid Arthritis, Anaphylaxis, Multiple Sclerosis, Diabetes and Other Therapies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
TABLE 37: USA 16-Year Perspective for Autoinjectors by Therapy - Percentage Breakdown of Value Sales for Rheumatoid Arthritis, Anaphylaxis, Multiple Sclerosis, Diabetes and Other Therapies for the Years 2014, 2023 & 2030
TABLE 38: USA Recent Past, Current & Future Analysis for Autoinjectors by Type - Disposable Autoinjectors and Reusable Autoinjectors - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
TABLE 39: USA Historic Review for Autoinjectors by Type - Disposable Autoinjectors and Reusable Autoinjectors Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
TABLE 40: USA 16-Year Perspective for Autoinjectors by Type - Percentage Breakdown of Value Sales for Disposable Autoinjectors and Reusable Autoinjectors for the Years 2014, 2023 & 2030
TABLE 41: USA Recent Past, Current & Future Analysis for Autoinjectors by End-Use - Home Care Settings, Hospitals & Clinics and Ambulatory Care Settings - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
TABLE 42: USA Historic Review for Autoinjectors by End-Use - Home Care Settings, Hospitals & Clinics and Ambulatory Care Settings Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
TABLE 43: USA 16-Year Perspective for Autoinjectors by End-Use - Percentage Breakdown of Value Sales for Home Care Settings, Hospitals & Clinics and Ambulatory Care Settings for the Years 2014, 2023 & 2030
CANADA
TABLE 44: Canada Recent Past, Current & Future Analysis for Autoinjectors by Therapy - Rheumatoid Arthritis, Anaphylaxis, Multiple Sclerosis, Diabetes and Other Therapies - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
TABLE 45: Canada Historic Review for Autoinjectors by Therapy - Rheumatoid Arthritis, Anaphylaxis, Multiple Sclerosis, Diabetes and Other Therapies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
TABLE 46: Canada 16-Year Perspective for Autoinjectors by Therapy - Percentage Breakdown of Value Sales for Rheumatoid Arthritis, Anaphylaxis, Multiple Sclerosis, Diabetes and Other Therapies for the Years 2014, 2023 & 2030
TABLE 47: Canada Recent Past, Current & Future Analysis for Autoinjectors by Type - Disposable Autoinjectors and Reusable Autoinjectors - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
TABLE 48: Canada Historic Review for Autoinjectors by Type - Disposable Autoinjectors and Reusable Autoinjectors Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
TABLE 49: Canada 16-Year Perspective for Autoinjectors by Type - Percentage Breakdown of Value Sales for Disposable Autoinjectors and Reusable Autoinjectors for the Years 2014, 2023 & 2030
TABLE 50: Canada Recent Past, Current & Future Analysis for Autoinjectors by End-Use - Home Care Settings, Hospitals & Clinics and Ambulatory Care Settings - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
TABLE 51: Canada Historic Review for Autoinjectors by End-Use - Home Care Settings, Hospitals & Clinics and Ambulatory Care Settings Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
TABLE 52: Canada 16-Year Perspective for Autoinjectors by End-Use - Percentage Breakdown of Value Sales for Home Care Settings, Hospitals & Clinics and Ambulatory Care Settings for the Years 2014, 2023 & 2030
JAPAN
Autoinjectors Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2023 (E)
TABLE 53: Japan Recent Past, Current & Future Analysis for Autoinjectors by Therapy - Rheumatoid Arthritis, Anaphylaxis, Multiple Sclerosis, Diabetes and Other Therapies - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
TABLE 54: Japan Historic Review for Autoinjectors by Therapy - Rheumatoid Arthritis, Anaphylaxis, Multiple Sclerosis, Diabetes and Other Therapies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
TABLE 55: Japan 16-Year Perspective for Autoinjectors by Therapy - Percentage Breakdown of Value Sales for Rheumatoid Arthritis, Anaphylaxis, Multiple Sclerosis, Diabetes and Other Therapies for the Years 2014, 2023 & 2030
TABLE 56: Japan Recent Past, Current & Future Analysis for Autoinjectors by Type - Disposable Autoinjectors and Reusable Autoinjectors - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
TABLE 57: Japan Historic Review for Autoinjectors by Type - Disposable Autoinjectors and Reusable Autoinjectors Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
TABLE 58: Japan 16-Year Perspective for Autoinjectors by Type - Percentage Breakdown of Value Sales for Disposable Autoinjectors and Reusable Autoinjectors for the Years 2014, 2023 & 2030
TABLE 59: Japan Recent Past, Current & Future Analysis for Autoinjectors by End-Use - Home Care Settings, Hospitals & Clinics and Ambulatory Care Settings - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
TABLE 60: Japan Historic Review for Autoinjectors by End-Use - Home Care Settings, Hospitals & Clinics and Ambulatory Care Settings Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
TABLE 61: Japan 16-Year Perspective for Autoinjectors by End-Use - Percentage Breakdown of Value Sales for Home Care Settings, Hospitals & Clinics and Ambulatory Care Settings for the Years 2014, 2023 & 2030
CHINA
Autoinjectors Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2023 (E)
TABLE 62: China Recent Past, Current & Future Analysis for Autoinjectors by Therapy - Rheumatoid Arthritis, Anaphylaxis, Multiple Sclerosis, Diabetes and Other Therapies - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
TABLE 63: China Historic Review for Autoinjectors by Therapy - Rheumatoid Arthritis, Anaphylaxis, Multiple Sclerosis, Diabetes and Other Therapies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
TABLE 64: China 16-Year Perspective for Autoinjectors by Therapy - Percentage Breakdown of Value Sales for Rheumatoid Arthritis, Anaphylaxis, Multiple Sclerosis, Diabetes and Other Therapies for the Years 2014, 2023 & 2030
TABLE 65: China Recent Past, Current & Future Analysis for Autoinjectors by Type - Disposable Autoinjectors and Reusable Autoinjectors - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
TABLE 66: China Historic Review for Autoinjectors by Type - Disposable Autoinjectors and Reusable Autoinjectors Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
TABLE 67: China 16-Year Perspective for Autoinjectors by Type - Percentage Breakdown of Value Sales for Disposable Autoinjectors and Reusable Autoinjectors for the Years 2014, 2023 & 2030
TABLE 68: China Recent Past, Current & Future Analysis for Autoinjectors by End-Use - Home Care Settings, Hospitals & Clinics and Ambulatory Care Settings - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
TABLE 69: China Historic Review for Autoinjectors by End-Use - Home Care Settings, Hospitals & Clinics and Ambulatory Care Settings Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
TABLE 70: China 16-Year Perspective for Autoinjectors by End-Use - Percentage Breakdown of Value Sales for Home Care Settings, Hospitals & Clinics and Ambulatory Care Settings for the Years 2014, 2023 & 2030
EUROPE
Autoinjectors Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2023 (E)
TABLE 71: Europe Recent Past, Current & Future Analysis for Autoinjectors by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2022 through 2030 and % CAGR
TABLE 72: Europe Historic Review for Autoinjectors by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
TABLE 73: Europe 16-Year Perspective for Autoinjectors by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets for Years 2014, 2023 & 2030
TABLE 74: Europe Recent Past, Current & Future Analysis for Autoinjectors by Therapy - Rheumatoid Arthritis, Anaphylaxis, Multiple Sclerosis, Diabetes and Other Therapies - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
TABLE 75: Europe Historic Review for Autoinjectors by Therapy - Rheumatoid Arthritis, Anaphylaxis, Multiple Sclerosis, Diabetes and Other Therapies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
TABLE 76: Europe 16-Year Perspective for Autoinjectors by Therapy - Percentage Breakdown of Value Sales for Rheumatoid Arthritis, Anaphylaxis, Multiple Sclerosis, Diabetes and Other Therapies for the Years 2014, 2023 & 2030
TABLE 77: Europe Recent Past, Current & Future Analysis for Autoinjectors by Type - Disposable Autoinjectors and Reusable Autoinjectors - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
TABLE 78: Europe Historic Review for Autoinjectors by Type - Disposable Autoinjectors and Reusable Autoinjectors Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
TABLE 79: Europe 16-Year Perspective for Autoinjectors by Type - Percentage Breakdown of Value Sales for Disposable Autoinjectors and Reusable Autoinjectors for the Years 2014, 2023 & 2030
TABLE 80: Europe Recent Past, Current & Future Analysis for Autoinjectors by End-Use - Home Care Settings, Hospitals & Clinics and Ambulatory Care Settings - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
TABLE 81: Europe Historic Review for Autoinjectors by End-Use - Home Care Settings, Hospitals & Clinics and Ambulatory Care Settings Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
TABLE 82: Europe 16-Year Perspective for Autoinjectors by End-Use - Percentage Breakdown of Value Sales for Home Care Settings, Hospitals & Clinics and Ambulatory Care Settings for the Years 2014, 2023 & 2030
FRANCE
Autoinjectors Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2023 (E)
TABLE 83: France Recent Past, Current & Future Analysis for Autoinjectors by Therapy - Rheumatoid Arthritis, Anaphylaxis, Multiple Sclerosis, Diabetes and Other Therapies - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
TABLE 84: France Historic Review for Autoinjectors by Therapy - Rheumatoid Arthritis, Anaphylaxis, Multiple Sclerosis, Diabetes and Other Therapies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
TABLE 85: France 16-Year Perspective for Autoinjectors by Therapy - Percentage Breakdown of Value Sales for Rheumatoid Arthritis, Anaphylaxis, Multiple Sclerosis, Diabetes and Other Therapies for the Years 2014, 2023 & 2030
TABLE 86: France Recent Past, Current & Future Analysis for Autoinjectors by Type - Disposable Autoinjectors and Reusable Autoinjectors - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
TABLE 87: France Historic Review for Autoinjectors by Type - Disposable Autoinjectors and Reusable Autoinjectors Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
TABLE 88: France 16-Year Perspective for Autoinjectors by Type - Percentage Breakdown of Value Sales for Disposable Autoinjectors and Reusable Autoinjectors for the Years 2014, 2023 & 2030
TABLE 89: France Recent Past, Current & Future Analysis for Autoinjectors by End-Use - Home Care Settings, Hospitals & Clinics and Ambulatory Care Settings - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
TABLE 90: France Historic Review for Autoinjectors by End-Use - Home Care Settings, Hospitals & Clinics and Ambulatory Care Settings Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
TABLE 91: France 16-Year Perspective for Autoinjectors by End-Use - Percentage Breakdown of Value Sales for Home Care Settings, Hospitals & Clinics and Ambulatory Care Settings for the Years 2014, 2023 & 2030
GERMANY
Autoinjectors Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2023 (E)
TABLE 92: Germany Recent Past, Current & Future Analysis for Autoinjectors by Therapy - Rheumatoid Arthritis, Anaphylaxis, Multiple Sclerosis, Diabetes and Other Therapies - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
TABLE 93: Germany Historic Review for Autoinjectors by Therapy - Rheumatoid Arthritis, Anaphylaxis, Multiple Sclerosis, Diabetes and Other Therapies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
TABLE 94: Germany 16-Year Perspective for Autoinjectors by Therapy - Percentage Breakdown of Value Sales for Rheumatoid Arthritis, Anaphylaxis, Multiple Sclerosis, Diabetes and Other Therapies for the Years 2014, 2023 & 2030
TABLE 95: Germany Recent Past, Current & Future Analysis for Autoinjectors by Type - Disposable Autoinjectors and Reusable Autoinjectors - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
TABLE 96: Germany Historic Review for Autoinjectors by Type - Disposable Autoinjectors and Reusable Autoinjectors Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
TABLE 97: Germany 16-Year Perspective for Autoinjectors by Type - Percentage Breakdown of Value Sales for Disposable Autoinjectors and Reusable Autoinjectors for the Years 2014, 2023 & 2030
TABLE 98: Germany Recent Past, Current & Future Analysis for Autoinjectors by End-Use - Home Care Settings, Hospitals & Clinics and Ambulatory Care Settings - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
TABLE 99: Germany Historic Review for Autoinjectors by End-Use - Home Care Settings, Hospitals & Clinics and Ambulatory Care Settings Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook
Cookie Settings